Patheon Looks To Establish Stronger Ties with Japanese Pharmas
This article was originally published in PharmAsia News
TOKYO - Toronto-based drug maker and developer Patheon created subsidiary Patheon K.K. in Tokyo this month in hopes of securing stronger ties with Japanese pharmaceutical companies
You may also be interested in...
BEIJING - WuXi PharmaTech is positioning itself to ride the rising tides of global pharmaceutical outsourcing to strengthen its role as China's largest contract research organization, according to a WuXi executive and an independent analyst
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).